Overexpression of mutant EGFR variant III (EGFRvIII), present in about 30% of nGBM [113], has been recognized as a tumor-specific, oncogenic epitope able to mediate increased cellular growth, invasion and angiogenesis, and resistance to chemoradiation in GBM cells [114]. The gene discussed is EGFR; the disease is glioblastoma.